NCM
GOSS icon

Nantahala Capital Management’s Gossamer Bio GOSS Stock Holding History

Nantahala Capital Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-8,411
Closed -$664K – 140
2024
Q3 		$664K Hold
8,411
– – 0.03% 120
2024
Q2 		$623K Hold
8,411
– – 0.04% 115
2024
Q1 		$794K Hold
8,411
– – 0.05% 106
2023
Q4 		$614K Sell
8,411
-67,707
-89% -$4M 0.04% 110
2023
Q3 		$5.07M Buy
+76,118
New +$7.02M 0.43% 54

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Nantahala Capital Management's GOSS Position: Q4 2024 in Review

Nantahala Capital Management sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 8,411 shares — an estimated $664K sold.

Nantahala Capital Management first reported a position in GOSS in Q3 2023 and held it in 5 quarters. The position peaked at $5.07M in Q3 2023. 102 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • Nantahala Capital Management reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • Nantahala Capital Management sold 8,411 Gossamer Bio shares in Q4 2024, an estimated $664K.
  • Nantahala Capital Management first reported a position in Gossamer Bio in Q3 2023 and held it in 5 quarters.
  • Nantahala Capital Management's Gossamer Bio position peaked at $5.07M in Q3 2023.
  • 102 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on Nantahala Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.